Search results
Earnings call: Verona Pharma reports Q1 2024 results, eyes COPD market By Investing.com
Investing.com· 6 days agoVerona Pharma (NASDAQ:VRNA) has announced its first quarter 2024 financial results, highlighting the...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 20 hours agoOlympus Highlighting COPD Treatment, AI-Driven Screening Process and EVIS X1 Bronchoscopes at American Thoracic Society Annual Meeting PR Newswire CENTER ...
Sanofi to make €1bn biomanufacturing investment in France
Pharmaceutical Technology via Yahoo Finance· 2 days agoThis will support future biologics and vaccine launches and accommodate the growth of Dupixent - on...
Three-time cancer survivor starts nonprofit, provides meals for seniors
The Star via Yahoo News· 2 hours agoHillman would drive to Asheville every Friday for classes and have radiation treatments the other...
BofA bullish on Apogee stock, sees significant market growth potential By Investing.com
Investing.com· 6 days agoFriday, BofA Securities initiated coverage on Apogee (NASDAQ:APOG) Therapeutics Inc (NASDAQ:APGE)...
Raleigh pharma secures $650M to be ready for growth surge - Triangle Business Journal
The Business Journals· 7 days agoWith a potential regulatory approval more than a month away, a biopharmaceutical company in Raleigh...
Pulmatrix reports progress in migraine treatment study By Investing.com
Investing.com· 19 hours agoPulmatrix, Inc. (NASDAQ:PULM), a biopharmaceutical company focusing on inhaled therapies, has...
Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update - Verona...
Benzinga· 7 days agoPDUFA Target Action Date for Ensifentrine of June 26, 2024 Finalizing commercial launch preparations Strong balance sheet supports commercialization and pipeline expansion Conference call today at 9:00 a.m. EDT /
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 19 hours agoThe company is working on a drug to treat liver fibrosis due to hepatitis B and metabolic...
Verona Pharma PLC Reports Q1 2024 Earnings: A Detailed Financial
Guru Focus· 6 days agoThe biopharmaceutical company, which focuses on developing treatments for respiratory diseases, reported a net loss and detailed its strategic preparations for the anticipated ...